CANADIAN BURDEN OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: FINAL RESULTS

被引：0
|
作者：
Zaour, N. [1 ]
Heisel, O. [2 ]
Leteneux, C. [3 ]
Ma, P. [4 ]
机构：
[1] Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada
[2] Syreon Corp, Vancouver, BC, Canada
[3] Novartis Pharma AG, Basel, Switzerland
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1657
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS10
引用
收藏
页码：A284 / A285
页数：2
相关论文
共 50 条
  • [1] CANADIAN BURDEN OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: FINAL RESULTS
    Zaour, Nancy
    Heisel, Olaf
    Ma, Patrick
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [2] CANADIAN BURDEN OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: BASELINE CHARACTERISTICS OF PATIENTS
    Zaour, N.
    Heisel, O.
    Barbeau, M.
    Ma, P.
    VALUE IN HEALTH, 2013, 16 (07) : A504 - A504
  • [3] Conbercept for treatment of choroidal neovascularization secondary to pathologic myopia
    Yan, Ming
    Huang, Zhen
    Lian, Hai-Yan
    Song, Yan-Ping
    Chen, Xiao
    ACTA OPHTHALMOLOGICA, 2019, 97 (05) : E813 - E814
  • [4] Choroidal Neovascularization in Pathologic Myopia
    Dave, Vivek
    Narayanan, Raja
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 150 (05) : 752 - 752
  • [5] PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
    HOTCHKISS, ML
    FINE, SL
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1981, 91 (02) : 177 - 183
  • [6] PREVALENCE, INCIDENCE AND CHARACTERISTICS OF PATIENTS WITH CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA IN A REPRESENTATIVE CANADIAN COHORT
    Pickering, Megan
    Luciani, Laura
    Zaour, Nancy
    Petrella, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [7] PREVALENCE, INCIDENCE AND CHARACTERISTICS OF PATIENTS WITH CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA IN A REPRESENTATIVE CANADIAN COHORT
    Zaour, N.
    Luciani, L.
    Petrella, R. J.
    VALUE IN HEALTH, 2014, 17 (03) : A283 - A284
  • [8] Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results
    Mones, J. M.
    Amselem, L.
    Serrano, A.
    Garcia, M.
    Hijano, M.
    EYE, 2009, 23 (06) : 1276 - 1280
  • [9] Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results
    J M Monés
    L Amselem
    A Serrano
    M Garcia
    M Hijano
    Eye, 2009, 23 : 1275 - 1281
  • [10] Transpupillary Thermotherapy of Subfoveal Choroidal Neovascularization Secondary to Pathologic Myopia
    Nabawi, Khaled S.
    Shaarawi, Ashraf S.
    OPHTHALMIC SURGERY LASERS & IMAGING, 2010, 41 (01) : 12 - 17
12345